Modulation of microRNAs expression in hematopoietic stem cells treated with sodium butyrate in inducing fetal hemoglobin expression

Artificial Cells, Nanomedicine, and Biotechnology
Behnoosh TayebiMansoureh Ajami

Abstract

Context Inherited hemoglobin diseases are the most common single-gene disorders. Induction of fetal hemoglobin in beta hemoglobin disorders compensate for abnormal chain and ameliorate the clinical complications. Sodium butyrate is used conventionally for fetal hemoglobin induction; it can be replaced by safer therapeutic tools like microRNAs, small non-coding RNAs that control number of epigenetic mechanisms. Objective In this study, we compared the changes in the microRNAs of differentiated erythroid cells between control and sodium butyrate treated groups. The objective is to find significant association between these changes and gamma chain up regulation. Materials and methods First, CD133(+ ) hematopoietic stem cells were isolated from cord blood by magnetic cell sorting (MACS) technique. After proliferation, the cells were differentiated to erythroid lineage in culture medium by EPO, SCF, and IL3. Meanwhile, the test group was treated with sodium butyrate. Then, gamma chain upregulation was verified by qPCR technique. Finally, microRNA profiling was performed through microarray assay and some of them confirmed by qPCR. Result Results demonstrated that gamma chain was 5.9-fold upregulated in the treated group. Significant ...Continue Reading

References

Jan 14, 1988·The New England Journal of Medicine·C T NoguchiA N Schechter
Jan 14, 1993·The New England Journal of Medicine·S P PerrineN F Olivieri
Mar 1, 1995·Current Opinion in Hematology·D V Faller, S P Perrine
Sep 12, 2001·Medicine·M H Steinberg, G P Rodgers
Oct 14, 2004·Blood·Rona S WeinbergGeorge F Atweh
Feb 26, 2005·Experimental Hematology·George Stamatoyannopoulos
Sep 16, 2005·The New England Journal of Medicine·Deborah Rund, Eliezer Rachmilewitz
Oct 18, 2005·British Journal of Haematology·Sylvia T SingerUNKNOWN E/beta Thalassaemia Study Group
Mar 3, 2006·Genes & Development·Marco Antonio Valencia-SanchezRoy Parker
May 13, 2006·Expert Reviews in Molecular Medicine·Catherine Madigan, Punam Malik
Nov 25, 2006·Hematology·Hassana Fathallah, George F Atweh
Mar 23, 2010·Haematologica·Marco GabbianelliCesare Peschle
May 25, 2010·Orphanet Journal of Rare Diseases·Renzo Galanello, Raffaella Origa
Dec 7, 2010·Lancet·David C ReesMark T Gladwin
Jan 6, 2011·Proceedings of the National Academy of Sciences of the United States of America·Vijay G SankaranHarvey F Lodish
Dec 14, 2011·Hematology·Vijay G Sankaran
Mar 30, 2013·Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology·Ali Dehghani FardNajmaldin Saki
Aug 10, 2013·Blood·Lydie Da Costa
Nov 26, 2014·Artificial Cells, Nanomedicine, and Biotechnology·Mehrak ZareNosratollah Zarghami
Apr 22, 2015·World Journal of Orthopedics·Joel A HumphreyStephen Bendall
May 20, 2015·Molecular and Cellular Biology·Yu-Chi ChouChe-Kun James Shen

❮ Previous
Next ❯

Citations

Dec 13, 2017·Journal of Cellular Biochemistry·Xiaoqiang XiaoHaoyu Chen
Feb 1, 2018·Journal of Cellular Physiology·Reza RanjbarBahman Yousefi
Mar 21, 2019·British Journal of Haematology·Athena Starlard-DavenportBetty S Pace
Mar 12, 2020·Annals of Hematology·Firdosh Shah, Mitesh Dwivedi
Jan 6, 2021·Annals of Hematology·Henu Kumar VermaRaffaella Colombatti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.